Isolator Technology: Industry Wants Revised Regulations To Encourage Use
Executive Summary
FDA should encourage the use of isolator technology by ensuring an open regulatory environment, committee guests agreed at the Pharmaceutical Science Advisory Committee meeting on Oct. 22
You may also be interested in...
FDA Manufacturing Subcmte. Should Track Industry/Agency Disputes – PhRMA
FDA's Pharmaceutical Science Advisory Committee's Manufacturing Subcommittee should track disputes between industry and the agency to identify areas in need of standards development, the Pharmaceutical Researchers & Manufacturers of America said
FDA Manufacturing Subcmte. Should Track Industry/Agency Disputes – PhRMA
FDA's Pharmaceutical Science Advisory Committee's Manufacturing Subcommittee should track disputes between industry and the agency to identify areas in need of standards development, the Pharmaceutical Researchers & Manufacturers of America said
Aseptic processing concept paper
FDA expects to release a "concept paper" on aseptic processing in time for the Pharmaceutical Science Advisory Committee to review it at a meeting tentatively scheduled for Oct. 21-22. Industry has called upon FDA to revise its guidance on aseptic processing (1"The Pink Sheet" April 22, p. 18). FDA's aseptic processing guidance was issued in 1987; the agency is preparing an updated draft guidance it hopes to publish by the end of the year...